S

Sparrow Pharmaceuticals, Inc.

9 employees

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Corticosteroids
Clinical trials
New chemical entity
Cushing's syndrome
Pharmaceutical
Drug development
Inflammatory diseases
Polymyalgia rheumatica
Therapeutics
Giant cell arteritis
Biopharma
Autoimmune diseases
Pharmaceuticals

Date founded

2013

Funding rounds raised

Total raised

$50M

from 2 investors over 2 rounds

S

Sparrow Pharmaceuticals, Inc. raised $50M on May 18, 2021

Investors: RiverVest Venture Partners and OrbiMed Advisors

FAQ